Patent · US Active

Gene signatures for monitoring acute rejection and methods of using same

US12084509B2 · kind B2 · utility

0Cited by
3References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2021
Grant dateSep 10, 2024
Priority date—
Expiry dateJun 11, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/245
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides methods and compositions for detecting and treating acute transplant rejection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.